title: PD1 and PD-L1 in ependymoma might not be therapeutic targets.
authors.forename: Benoit
authors.initials: B
authors.lastname: Dumont
authors.forename: Fabien
authors.initials: F
authors.lastname: Forest
authors.forename: Pierre
authors.initials: P
authors.lastname: Dal Col
authors.forename: Georgia
authors.initials: G
authors.lastname: Karpathiou
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Stephan
authors.forename: François
authors.initials: F
authors.lastname: Vassal
authors.forename: Michel
authors.initials: M
authors.lastname: Péoc'h
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D060890:B7-H1 Antigen / Q000032:analysis / Q000096:biosynthesis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D016543:Central Nervous System Neoplasms / Q000378:metabolism / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D004806:Ependymoma / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D061026:Programmed Cell Death 1 Receptor / Q000032:analysis / Q000096:biosynthesis*; D055815:Young Adult
chemical_list: D060890:B7-H1 Antigen; D014408:Biomarkers, Tumor; C423236:CD274 protein, human; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor